NO147626C - PROCEDURE FOR THE PREPARATION OF A MEDICAL PREPARATION WITH DELAYED RELEASE OF THE THERAPEUTIC ACTIVE INGREDIENT - Google Patents

PROCEDURE FOR THE PREPARATION OF A MEDICAL PREPARATION WITH DELAYED RELEASE OF THE THERAPEUTIC ACTIVE INGREDIENT

Info

Publication number
NO147626C
NO147626C NO774051A NO774051A NO147626C NO 147626 C NO147626 C NO 147626C NO 774051 A NO774051 A NO 774051A NO 774051 A NO774051 A NO 774051A NO 147626 C NO147626 C NO 147626C
Authority
NO
Norway
Prior art keywords
preparation
procedure
active ingredient
delayed release
therapeutic active
Prior art date
Application number
NO774051A
Other languages
Norwegian (no)
Other versions
NO147626B (en
NO774051L (en
Inventor
Yegnaswami Raghunathan
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of NO774051L publication Critical patent/NO774051L/en
Publication of NO147626B publication Critical patent/NO147626B/en
Publication of NO147626C publication Critical patent/NO147626C/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
NO774051A 1976-11-26 1977-11-25 PROCEDURE FOR THE PREPARATION OF A MEDICAL PREPARATION WITH DELAYED RELEASE OF THE THERAPEUTIC ACTIVE INGREDIENT NO147626C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (3)

Publication Number Publication Date
NO774051L NO774051L (en) 1978-05-29
NO147626B NO147626B (en) 1983-02-07
NO147626C true NO147626C (en) 1983-05-25

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
NO774051A NO147626C (en) 1976-11-26 1977-11-25 PROCEDURE FOR THE PREPARATION OF A MEDICAL PREPARATION WITH DELAYED RELEASE OF THE THERAPEUTIC ACTIVE INGREDIENT

Country Status (21)

Country Link
JP (1) JPS609697B2 (en)
AR (1) AR218047A1 (en)
AT (1) AT359197B (en)
AU (1) AU511080B2 (en)
BE (1) BE861141A (en)
CA (1) CA1086226A (en)
CH (1) CH639560A5 (en)
DE (1) DE2752728C2 (en)
DK (1) DK150534C (en)
FI (1) FI65910C (en)
FR (1) FR2373288A1 (en)
GB (1) GB1544761A (en)
GR (1) GR61724B (en)
IE (1) IE45998B1 (en)
IL (1) IL53462A (en)
LU (1) LU78584A1 (en)
NL (1) NL182283C (en)
NO (1) NO147626C (en)
NZ (1) NZ185772A (en)
PT (1) PT67323B (en)
SE (1) SE426781B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (en) 1979-07-20 1981-02-05 Lentia Gmbh COMPOSITION WITH EXTENDED BRONCHOLYTIC AND TOCOLYTIC EFFECTIVENESS, A METHOD FOR THE PRODUCTION THEREOF AND BRONCHOLYTIC AND TOKOLYTICALLY ACTIVE AGENT
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
FR3059903B1 (en) * 2016-12-08 2019-03-22 Salsarulo Pharma ORAL MEDICINE COMPRISING AN OSMOTIC LAXATIVE INCORPORATED IN A MATRIX BASED ON VEGETABLE FATS
JP2020536892A (en) 2017-10-09 2020-12-17 ローズ ファーマシューティカルズ エル．ピー． Pharmaceutical resinate composition, how to make it, and its use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (en) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (en) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Pellets containing furosemide

Also Published As

Publication number Publication date
JPS609697B2 (en) 1985-03-12
PT67323A (en) 1977-12-01
NO147626B (en) 1983-02-07
FI773568A (en) 1978-05-27
FR2373288B1 (en) 1980-06-13
CA1086226A (en) 1980-09-23
AT359197B (en) 1980-10-27
AU3098677A (en) 1979-05-31
DK150534C (en) 1987-10-12
SE7713370L (en) 1978-05-27
IE45998L (en) 1978-05-26
IL53462A (en) 1980-12-31
LU78584A1 (en) 1978-04-20
SE426781B (en) 1983-02-14
NZ185772A (en) 1978-12-18
NL7712996A (en) 1978-05-30
AR218047A1 (en) 1980-05-15
NL182283B (en) 1987-09-16
GR61724B (en) 1978-12-29
AU511080B2 (en) 1980-07-24
GB1544761A (en) 1979-04-25
DK523277A (en) 1978-05-27
NO774051L (en) 1978-05-29
ATA848077A (en) 1980-03-15
FI65910B (en) 1984-04-30
PT67323B (en) 1979-04-24
FI65910C (en) 1984-08-10
CH639560A5 (en) 1983-11-30
IE45998B1 (en) 1983-01-26
JPS5369822A (en) 1978-06-21
FR2373288A1 (en) 1978-07-07
DE2752728C2 (en) 1985-08-01
DK150534B (en) 1987-03-23
DE2752728A1 (en) 1978-06-01
NL182283C (en) 1988-02-16
IL53462A0 (en) 1978-01-31
BE861141A (en) 1978-03-16

Similar Documents

Publication Publication Date Title
NO149962C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE IMIDAZOLD DERIVATIVES
NO150361C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 3- (1H-TETRAZOL-5-YL) -4H- (PYRIDO- (1,2-A) -PYRIMIDIN-4-ON DERIVATIVES)
NO782127L (en) PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICAL ACTIVE ISOKSAZOLO-PYRIDINE DERIVATIVES
NO148148C (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4-HYDROXY-2-PYRROLIDINON DERIVATIVES
NO784211L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE ACYLANILIDE DERIVATIVES
NO784231L (en) ANALOGICAL PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE BENZOTIAZINE DERIVATIVES
NO151321C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CARBOSTYRIC DERIVATIVES
NO151463C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CHINAZOLINE DERIVATIVES
NO800858L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 4-AMINO-3-QUINOLINCARBOXYLIC ACID DERIVATIVES
NO148957C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE CYCLOPEPTIDES
NO150360C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BRAND CAPACYLDIPEPTIDES
NO800881L (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE QUINOLO DERIVATIVES
NO782756L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ANTHRAKINON DERIVATIVES
NO147626C (en) PROCEDURE FOR THE PREPARATION OF A MEDICAL PREPARATION WITH DELAYED RELEASE OF THE THERAPEUTIC ACTIVE INGREDIENT
NO149313C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDOBENZODIAZEPINES
NO151319C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE BETA-MONO-FLUORMETHYL-BETA-ALANINE AND BETA-DIFLUORMETHYL-BETA-ALANINE COMPOUNDS
NO149037C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE PYRIDOBENZODIAZEPINES
NO148451C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE OXIMETERS
NO150158C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 6,7-DIMETOXYQUINAZOLINE DERIVATIVES
NO149314C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF PHYSIOLOGICALLY ACTIVE IMIDAZOISOKINOL INDIONS
NO780644L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 9-HYDROXYETHOXYMETHYLGUANINE DERIVATIVES
NO152172C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE SPIRO-CHINOLYL-HYDANTOIN DERIVATIVES
NO152556C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE ANTRACEN-BISCARBONYL HYDRAZONS
NO151861C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-SUBSTITUTED-10,11-DIHYDRO-5H-DIBENZO- (A, D) -CYCLOHEPTEN-5,10-IMINER
NO145656C (en) ANALOGY PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 1-PHENYLETANOLAMINE DERIVATIVES